Respiratory

Long-term PAP therapy may boost survival in patients with COPD and OSA, highlighting potential benefits of early diagnosis and proactive respiratory management.

High Flow Nasal Cannula therapy may reduce the need for ventilation in severe COVID-19 cases, improving oxygenation and ICU outcomes.

A Swedish study, using data from the BAMSE birth cohort, has shown that childhood body mass index (BMI) trajectories can have lasting effects on lung health, with certain patterns linked to reduced lung function by early adulthood.

Recent studies and meta-analyses have investigated the impact of PM2.5 on asthma, yet findings remain inconsistent.

A NEW clinical trial has found that the asthma drug montelukast does not shorten the duration of symptoms for mild-to-moderate COVID-19 patients compared to a placebo.

A new study has shown that dual bronchodilator therapy can help reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD), with notable differences in efficacy between current and former smokers.

Detection of SARS-CoV-2 RNA on the floors of healthcare worker-only areas in hospitals is strongly associated with impending COVID-19 outbreaks in hospital wards.

Findings from ERS 2024 show that continuing anticoagulation after the acute phase of COVID-19 significantly reduces the risk of venous thromboembolism in recovering patients.